GENESIS HEALTHCARE INC

GENESIS HEALTHCARE INC

OOTC:GENNQ
0.00
USD
0.00
(0.00%)
-0.82EPS
Nov 09Next Earn

Important Dates

GENESIS HEALTHCARE INC's next confirmed earnings release is scheduled for November 9, 2026.

Earnings Date11/9/2026

Share Statistics

As of December 31, 2020, GENESIS HEALTHCARE INC has 111.55M shares outstanding.

Shares Outstanding111.55M

Financial Position

As of December 31, 2020, GENESIS HEALTHCARE INC maintains a current ratio of 0.23, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -327.83, indicating conservative leverage, while an interest coverage ratio of -1.34 demonstrates limited ability to service its debt obligations.

Current Ratio0.23
Quick Ratio0.17
Debt / Equity-327.83
Debt / EBITDA-20.94
Interest Coverage-1.34

Financial Efficiency

USD

These figures cover the twelve months ended December 31, 2020. Return on assets (ROA) is negative at -1.35, reflecting losses generated across the asset base. The company generates approximately 73,702.32 in revenue per employee across its workforce of 53,000.00, a quick read on workforce productivity versus industry peers.

Return on Assets (ROA)-1.35
Revenue Per Employee73,702.32
Employee Count53,000.00

Taxes

USD

Over the twelve months ended December 31, 2020, GENESIS HEALTHCARE INC recorded an income tax benefit of -3.61M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -106.98M and -58.96M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax-3.61M

Income Statement

USD

Over the twelve months ended December 31, 2020, GENESIS HEALTHCARE INC generated 3.91B in revenue and converted that into -58.96M in net income, yielding earnings per share of -0.82. EBITDA reached -181.93M, while operating income came in at -269.78M.

Revenue3.91B
Gross Profit1.65B
Operating Income-269.78M
Pretax Income-106.98M
Net Income-58.96M
EBITDA-181.93M
EBIT-289.76M
Earnings Per Share (EPS)-0.82

Balance Sheet

USD

As of December 31, 2020, GENESIS HEALTHCARE INC holds 212.07M in cash and equivalents against 3.81B in total debt, resulting in a net debt position of 1.33B. Total book value stands at -820.22M, with working capital of -2.98B providing operational flexibility.

Cash & Cash Equivalents212.07M
Total Debt3.81B
Net Debt1.33B
Equity (Book Value)-820.22M
Book Value Per Share-7.35
Working Capital-2.98B

Cash Flow

USD

GENESIS HEALTHCARE INC produced 315.73M in operating cash flow over the twelve months ended December 31, 2020.

Operating Cash Flow315.73M
Free Cash Flow315.73M
FCF Per Share2.83

Margins

Over the twelve months ended December 31, 2020, GENESIS HEALTHCARE INC posted a gross margin of 42.24, reflecting its pricing power and cost economics. The operating margin of -6.91 and net profit margin of -1.51 provide insight into operational efficiency.

Gross Margin42.24
Operating Margin-6.91
Pretax Margin-2.74
Profit Margin-1.51
EBITDA Margin-4.66